Oligomers and oligomer conjugates
US-12281307-B2 · Apr 22, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ottosen Søren patents
Ottosen Søren is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ottosen Søren |
| Total patents | 32 |
| First publication | Dec 24, 2015 |
| Latest publication | Apr 22, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION
US-2024182898-A1 · Jun 6, 2024 · US
Enhanced oligonucleotides for inhibiting RTEL1 expression
US-11898145-B2 · Feb 13, 2024 · US
Oligomers and oligomer conjugates
US-2024035032-A1 · Feb 1, 2024 · US
Oligonucleotide treatment of hepatitis b patients
US-2023357773-A1 · Nov 9, 2023 · US
Pharmaceutical combination of antiviral agents targeting hbv and/or an immune modulator for treatment of hbv
US-2023123601-A1 · Apr 20, 2023 · US
Pharmaceutical combination of a therapeutic oligonucleotide targeting hbv and a tlr7 agonist for treatment of hbv
US-2023119360-A1 · Apr 20, 2023 · US
Oligomers and oligomer conjugates
US-11591598-B2 · Feb 28, 2023 · US
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection
US-11534452-B2 · Dec 27, 2022 · US
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
US-11484546-B2 · Nov 1, 2022 · US
Recent patents
Latest publications not already listed above.
Oligonucleotides for reduction of PD-L1 expression
US-11466081-B2 · Oct 11, 2022 · US
Enhanced oligonucleotides for inhibiting rtel1 expression
US-2022251556-A1 · Aug 11, 2022 · US
Antisense oligonucleotides for modulating htra1 expression
US-2022042022-A1 · Feb 10, 2022 · US
Enhanced oligonucleotides for modulating fubp1 expression
US-2022031730-A1 · Feb 3, 2022 · US
Oligonucleotides for reduction of pd-l1 expression
US-2021147535-A1 · May 20, 2021 · US
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
US-10953034-B2 · Mar 23, 2021 · US
Oligomers and oligomer conjugates
US-2021054381-A1 · Feb 25, 2021 · US
Oligonucleotides for reduction of PD-L1 expression
US-10829555-B2 · Nov 10, 2020 · US
Oligomers and oligomer conjugates
US-10767181-B2 · Sep 8, 2020 · US
Oligonucleotides for reduction of PD-L1 expression
US-10745480-B2 · Aug 18, 2020 · US
Oligonucleotides for reduction of pd-l1 expression
US-2020247884-A1 · Aug 6, 2020 · US
Antisense oligonucleotides for modulating htra1 expression
US-2020157546-A1 · May 21, 2020 · US
NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTION
US-2020147123-A1 · May 14, 2020 · US
Oligonucleotides for reduction of pd-l1 expression
US-2020048344-A1 · Feb 13, 2020 · US
Oligomers and oligomer conjugates
US-2020024605-A1 · Jan 23, 2020 · US
Oligomers and oligomer conjugates
US-10421967-B2 · Sep 24, 2019 · US
Nucleic acid molecules for reduction of papd5 or papd7 mrna for treating hepatitis b infection
US-2019216846-A1 · Jul 18, 2019 · US
NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTION
US-2019111073-A1 · Apr 18, 2019 · US
Antisense oligonucleotides for modulating htra1 expression
US-2019055564-A1 · Feb 21, 2019 · US
Oligonucleotides for reduction of pd-l1 expression
US-2017283496-A1 · Oct 5, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 28 |
| Hoffmann La Roche | 6 |
| Roche Innovation Ct Copenhagen As | 5 |
| Dicerna Pharmaceuticals Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/3231 | 29 |
| C12N2310/11 | 29 |
| A61P31/20 | 28 |
| C12N2310/315 | 28 |
| C12N2310/351 | 27 |